Company / Operating Margin
Oncology Institute, Inc. Operating Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-15.3%
FY2025
5-year range
-32.5% / -4.4%
FY2021-FY2025
Trend
+35.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -32.5% to -15.3% over the past 2 years.
Based on SEC 10-K filings.
-15.3% in FY2025 with a 3-year CAGR of +7.3%.
Improved from -32.5% to -15.3% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +7.3pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 35.7% year-over-year.
- Peak operating margin was recorded in FY2021.
- Lowest operating margin in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -15.3% | +35.7% |
| FY2024 | -23.8% | +26.8% |
| FY2023 | -32.5% | -43.7% |
| FY2022 | -22.6% | -416.9% |
| FY2021 | -4.4% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026